Frequency of glomerular dysfunction in children with Beta thalassaemia major

Basma A Ali1, Ahmed M Mahmoud1

  • 1Department of Pediatrics, University Children Hospital, Minia University, Minia, Egypt.

Insights

Children with beta thalassaemia major (β-TM) often experience glomerular dysfunction. Cystatin C shows promise as a sensitive marker for monitoring kidney health in these patients.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Biochemistry

Background:

  • Beta thalassaemia major (β-TM) is a severe inherited blood disorder.
  • Chronic anemia and iron overload are common in β-TM patients.
  • Potential for kidney complications necessitates investigation.

Purpose of the Study:

  • To determine the frequency of glomerular dysfunction in children with β-TM.
  • To evaluate different markers of kidney function.
  • To correlate these markers with serum ferritin and iron chelation therapy.

Main Methods:

  • Study included 100 β-TM patients (two groups: chelation therapy vs. follow-up) and 50 healthy controls.
  • Assessed cystatin C, serum creatinine, serum ferritin, urine albumin/creatinine ratio, estimated glomerular filtration rate (eGFR), and creatinine clearance.
  • Compared markers between patient groups and controls.

Main Results:

  • β-TM patients showed significantly higher cystatin C, serum creatinine, serum ferritin, and urine albumin/creatinine ratio compared to controls.
  • Patients had significantly lower eGFR and creatinine clearance.
  • Cystatin C demonstrated higher sensitivity and specificity for detecting small GFR changes than serum creatinine and creatinine clearance.

Conclusions:

  • Glomerular dysfunction is frequent in β-TM, potentially due to anemia, iron overload, or chelation therapy.
  • Regular renal assessment is crucial for early detection of complications.
  • Cystatin C is a valuable marker for monitoring glomerular dysfunction in β-TM.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.2K
Glomerular Filtration Rate and its Regulation01:28

Glomerular Filtration Rate and its Regulation

The Glomerular Filtration Rate (GFR) is a measure of kidney function, reflecting the volume of filtrate formed per minute in the kidneys. On average, GFR is approximately 125 mL/min in males and 105 mL/min in females. Maintaining a relatively constant GFR is essential for the kidneys to effectively regulate body fluid homeostasis and maintain extracellular stability.
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
5.9K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.7K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271